[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Corticosteroid Injections for Joint Pain Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

July 2022 | 109 pages | ID: G4484C0BEA7EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The Corticosteroid Injections for Joint Pain market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Corticosteroid Injections for Joint Pain market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Hospital Pharmacies accounting for % of the Corticosteroid Injections for Joint Pain global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Knee & Ankle segment is altered to a % CAGR between 2022 and 2028.

Global key manufacturers of Corticosteroid Injections for Joint Pain include Allergan, Pfizer, Sanofi, Anika Therapeutics, and Ferring, etc. In terms of revenue, the global top four players hold a share over % in 2021.

Market segmentation

Corticosteroid Injections for Joint Pain market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
  • Knee & Ankle
  • Hip Joint
  • Shoulder & Elbow
  • Facet Joints of the Spine
  • Others
Market segment by Application can be divided into
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
The key market players for global Corticosteroid Injections for Joint Pain market are listed below:
  • Allergan
  • Pfizer
  • Sanofi
  • Anika Therapeutics
  • Ferring
  • Bioventus
  • Flexion Therapeutics
  • Zimmer Biomet
  • SEIKAGAKU
  • Chugai Pharma
Market segment by region, regional analysis covers
  • North America (United States, Canada and Mexico)
  • Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
  • South America (Brazil, Argentina, Colombia, and Rest of South America)
  • Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:

Chapter 1, to describe Corticosteroid Injections for Joint Pain product scope, market overview, market opportunities, market driving force and market risks.

Chapter 2, to profile the top manufacturers of Corticosteroid Injections for Joint Pain, with price, sales, revenue and global market share of Corticosteroid Injections for Joint Pain from 2019 to 2022.

Chapter 3, the Corticosteroid Injections for Joint Pain competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Corticosteroid Injections for Joint Pain breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.

Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Corticosteroid Injections for Joint Pain market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Corticosteroid Injections for Joint Pain.

Chapter 13, 14, and 15, to describe Corticosteroid Injections for Joint Pain sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 MARKET OVERVIEW

1.1 Corticosteroid Injections for Joint Pain Introduction
1.2 Market Analysis by Type
  1.2.1 Overview: Global Corticosteroid Injections for Joint Pain Revenue by Type: 2017 Versus 2021 Versus 2028
  1.2.2 Knee & Ankle
  1.2.3 Hip Joint
  1.2.4 Shoulder & Elbow
  1.2.5 Facet Joints of the Spine
  1.2.6 Others
1.3 Market Analysis by Application
  1.3.1 Overview: Global Corticosteroid Injections for Joint Pain Revenue by Application: 2017 Versus 2021 Versus 2028
  1.3.2 Hospital Pharmacies
  1.3.3 Retail Pharmacies
  1.3.4 Online Pharmacies
1.4 Global Corticosteroid Injections for Joint Pain Market Size & Forecast
  1.4.1 Global Corticosteroid Injections for Joint Pain Sales in Value (2017 & 2021 & 2028)
  1.4.2 Global Corticosteroid Injections for Joint Pain Sales in Volume (2017-2028)
  1.4.3 Global Corticosteroid Injections for Joint Pain Price (2017-2028)
1.5 Global Corticosteroid Injections for Joint Pain Production Capacity Analysis
  1.5.1 Global Corticosteroid Injections for Joint Pain Total Production Capacity (2017-2028)
  1.5.2 Global Corticosteroid Injections for Joint Pain Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
  1.6.1 Corticosteroid Injections for Joint Pain Market Drivers
  1.6.2 Corticosteroid Injections for Joint Pain Market Restraints
  1.6.3 Corticosteroid Injections for Joint Pain Trends Analysis

2 MANUFACTURERS PROFILES

2.1 Allergan
  2.1.1 Allergan Details
  2.1.2 Allergan Major Business
  2.1.3 Allergan Corticosteroid Injections for Joint Pain Product and Services
  2.1.4 Allergan Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Pfizer
  2.2.1 Pfizer Details
  2.2.2 Pfizer Major Business
  2.2.3 Pfizer Corticosteroid Injections for Joint Pain Product and Services
  2.2.4 Pfizer Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Sanofi
  2.3.1 Sanofi Details
  2.3.2 Sanofi Major Business
  2.3.3 Sanofi Corticosteroid Injections for Joint Pain Product and Services
  2.3.4 Sanofi Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 Anika Therapeutics
  2.4.1 Anika Therapeutics Details
  2.4.2 Anika Therapeutics Major Business
  2.4.3 Anika Therapeutics Corticosteroid Injections for Joint Pain Product and Services
  2.4.4 Anika Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 Ferring
  2.5.1 Ferring Details
  2.5.2 Ferring Major Business
  2.5.3 Ferring Corticosteroid Injections for Joint Pain Product and Services
  2.5.4 Ferring Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Bioventus
  2.6.1 Bioventus Details
  2.6.2 Bioventus Major Business
  2.6.3 Bioventus Corticosteroid Injections for Joint Pain Product and Services
  2.6.4 Bioventus Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Flexion Therapeutics
  2.7.1 Flexion Therapeutics Details
  2.7.2 Flexion Therapeutics Major Business
  2.7.3 Flexion Therapeutics Corticosteroid Injections for Joint Pain Product and Services
  2.7.4 Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Zimmer Biomet
  2.8.1 Zimmer Biomet Details
  2.8.2 Zimmer Biomet Major Business
  2.8.3 Zimmer Biomet Corticosteroid Injections for Joint Pain Product and Services
  2.8.4 Zimmer Biomet Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 SEIKAGAKU
  2.9.1 SEIKAGAKU Details
  2.9.2 SEIKAGAKU Major Business
  2.9.3 SEIKAGAKU Corticosteroid Injections for Joint Pain Product and Services
  2.9.4 SEIKAGAKU Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Chugai Pharma
  2.10.1 Chugai Pharma Details
  2.10.2 Chugai Pharma Major Business
  2.10.3 Chugai Pharma Corticosteroid Injections for Joint Pain Product and Services
  2.10.4 Chugai Pharma Corticosteroid Injections for Joint Pain Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)

3 CORTICOSTEROID INJECTIONS FOR JOINT PAIN BREAKDOWN DATA BY MANUFACTURER

3.1 Global Corticosteroid Injections for Joint Pain Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Corticosteroid Injections for Joint Pain Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Corticosteroid Injections for Joint Pain
3.4 Market Concentration Rate
  3.4.1 Top 3 Corticosteroid Injections for Joint Pain Manufacturer Market Share in 2021
  3.4.2 Top 6 Corticosteroid Injections for Joint Pain Manufacturer Market Share in 2021
3.5 Global Corticosteroid Injections for Joint Pain Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Corticosteroid Injections for Joint Pain Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions

4 MARKET ANALYSIS BY REGION

4.1 Global Corticosteroid Injections for Joint Pain Market Size by Region
  4.1.1 Global Corticosteroid Injections for Joint Pain Sales in Volume by Region (2017-2028)
  4.1.2 Global Corticosteroid Injections for Joint Pain Revenue by Region (2017-2028)
4.2 North America Corticosteroid Injections for Joint Pain Revenue (2017-2028)
4.3 Europe Corticosteroid Injections for Joint Pain Revenue (2017-2028)
4.4 Asia-Pacific Corticosteroid Injections for Joint Pain Revenue (2017-2028)
4.5 South America Corticosteroid Injections for Joint Pain Revenue (2017-2028)
4.6 Middle East and Africa Corticosteroid Injections for Joint Pain Revenue (2017-2028)

5 MARKET SEGMENT BY TYPE

5.1 Global Corticosteroid Injections for Joint Pain Sales in Volume by Type (2017-2028)
5.2 Global Corticosteroid Injections for Joint Pain Revenue by Type (2017-2028)
5.3 Global Corticosteroid Injections for Joint Pain Price by Type (2017-2028)

6 MARKET SEGMENT BY APPLICATION

6.1 Global Corticosteroid Injections for Joint Pain Sales in Volume by Application (2017-2028)
6.2 Global Corticosteroid Injections for Joint Pain Revenue by Application (2017-2028)
6.3 Global Corticosteroid Injections for Joint Pain Price by Application (2017-2028)

7 NORTH AMERICA BY COUNTRY, BY TYPE, AND BY APPLICATION

7.1 North America Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
7.2 North America Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
7.3 North America Corticosteroid Injections for Joint Pain Market Size by Country
  7.3.1 North America Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028)
  7.3.2 North America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
  7.3.3 United States Market Size and Forecast (2017-2028)
  7.3.4 Canada Market Size and Forecast (2017-2028)
  7.3.5 Mexico Market Size and Forecast (2017-2028)

8 EUROPE BY COUNTRY, BY TYPE, AND BY APPLICATION

8.1 Europe Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
8.2 Europe Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
8.3 Europe Corticosteroid Injections for Joint Pain Market Size by Country
  8.3.1 Europe Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028)
  8.3.2 Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
  8.3.3 Germany Market Size and Forecast (2017-2028)
  8.3.4 France Market Size and Forecast (2017-2028)
  8.3.5 United Kingdom Market Size and Forecast (2017-2028)
  8.3.6 Russia Market Size and Forecast (2017-2028)
  8.3.7 Italy Market Size and Forecast (2017-2028)

9 ASIA-PACIFIC BY REGION, BY TYPE, AND BY APPLICATION

9.1 Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
9.2 Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
9.3 Asia-Pacific Corticosteroid Injections for Joint Pain Market Size by Region
  9.3.1 Asia-Pacific Corticosteroid Injections for Joint Pain Sales in Volume by Region (2017-2028)
  9.3.2 Asia-Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2017-2028)
  9.3.3 China Market Size and Forecast (2017-2028)
  9.3.4 Japan Market Size and Forecast (2017-2028)
  9.3.5 Korea Market Size and Forecast (2017-2028)
  9.3.6 India Market Size and Forecast (2017-2028)
  9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
  9.3.8 Australia Market Size and Forecast (2017-2028)

10 SOUTH AMERICA BY REGION, BY TYPE, AND BY APPLICATION

10.1 South America Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
10.2 South America Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
10.3 South America Corticosteroid Injections for Joint Pain Market Size by Country
  10.3.1 South America Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028)
  10.3.2 South America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
  10.3.3 Brazil Market Size and Forecast (2017-2028)
  10.3.4 Argentina Market Size and Forecast (2017-2028)

11 MIDDLE EAST & AFRICA BY COUNTRY, BY TYPE, AND BY APPLICATION

11.1 Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Type (2017-2028)
11.2 Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Application (2017-2028)
11.3 Middle East & Africa Corticosteroid Injections for Joint Pain Market Size by Country
  11.3.1 Middle East & Africa Corticosteroid Injections for Joint Pain Sales in Volume by Country (2017-2028)
  11.3.2 Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Country (2017-2028)
  11.3.3 Turkey Market Size and Forecast (2017-2028)
  11.3.4 Egypt Market Size and Forecast (2017-2028)
  11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
  11.3.6 South Africa Market Size and Forecast (2017-2028)

12 RAW MATERIAL AND INDUSTRY CHAIN

12.1 Raw Material of Corticosteroid Injections for Joint Pain and Key Manufacturers
12.2 Manufacturing Costs Percentage of Corticosteroid Injections for Joint Pain
12.3 Corticosteroid Injections for Joint Pain Production Process
12.4 Corticosteroid Injections for Joint Pain Industrial Chain

13 SALES CHANNEL, DISTRIBUTORS, TRADERS AND DEALERS

13.1 Sales Channel
  13.1.1 Direct Marketing
  13.1.2 Indirect Marketing
13.2 Corticosteroid Injections for Joint Pain Typical Distributors
13.3 Corticosteroid Injections for Joint Pain Typical Customers

14 RESEARCH FINDINGS AND CONCLUSION

15 APPENDIX

15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

LIST OF TABLES

Table 1. Global Corticosteroid Injections for Joint Pain Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Corticosteroid Injections for Joint Pain Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Allergan Basic Information, Manufacturing Base and Competitors
Table 4. Allergan Major Business
Table 5. Allergan Corticosteroid Injections for Joint Pain Product and Services
Table 6. Allergan Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Pfizer Basic Information, Manufacturing Base and Competitors
Table 8. Pfizer Major Business
Table 9. Pfizer Corticosteroid Injections for Joint Pain Product and Services
Table 10. Pfizer Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Sanofi Basic Information, Manufacturing Base and Competitors
Table 12. Sanofi Major Business
Table 13. Sanofi Corticosteroid Injections for Joint Pain Product and Services
Table 14. Sanofi Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. Anika Therapeutics Basic Information, Manufacturing Base and Competitors
Table 16. Anika Therapeutics Major Business
Table 17. Anika Therapeutics Corticosteroid Injections for Joint Pain Product and Services
Table 18. Anika Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. Ferring Basic Information, Manufacturing Base and Competitors
Table 20. Ferring Major Business
Table 21. Ferring Corticosteroid Injections for Joint Pain Product and Services
Table 22. Ferring Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Bioventus Basic Information, Manufacturing Base and Competitors
Table 24. Bioventus Major Business
Table 25. Bioventus Corticosteroid Injections for Joint Pain Product and Services
Table 26. Bioventus Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Flexion Therapeutics Basic Information, Manufacturing Base and Competitors
Table 28. Flexion Therapeutics Major Business
Table 29. Flexion Therapeutics Corticosteroid Injections for Joint Pain Product and Services
Table 30. Flexion Therapeutics Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Zimmer Biomet Basic Information, Manufacturing Base and Competitors
Table 32. Zimmer Biomet Major Business
Table 33. Zimmer Biomet Corticosteroid Injections for Joint Pain Product and Services
Table 34. Zimmer Biomet Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. SEIKAGAKU Basic Information, Manufacturing Base and Competitors
Table 36. SEIKAGAKU Major Business
Table 37. SEIKAGAKU Corticosteroid Injections for Joint Pain Product and Services
Table 38. SEIKAGAKU Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Chugai Pharma Basic Information, Manufacturing Base and Competitors
Table 40. Chugai Pharma Major Business
Table 41. Chugai Pharma Corticosteroid Injections for Joint Pain Product and Services
Table 42. Chugai Pharma Corticosteroid Injections for Joint Pain Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Corticosteroid Injections for Joint Pain Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Corticosteroid Injections for Joint Pain Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Corticosteroid Injections for Joint Pain, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Corticosteroid Injections for Joint Pain Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Corticosteroid Injections for Joint Pain Production Site of Key Manufacturer
Table 48. Corticosteroid Injections for Joint Pain New Entrant and Capacity Expansion Plans
Table 49. Corticosteroid Injections for Joint Pain Mergers & Acquisitions in the Past Five Years
Table 50. Global Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
Table 51. Global Corticosteroid Injections for Joint Pain Sales by Region (2023-2028) & (K Units)
Table 52. Global Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
Table 55. Global Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
Table 56. Global Corticosteroid Injections for Joint Pain Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Corticosteroid Injections for Joint Pain Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Corticosteroid Injections for Joint Pain Price by Type (2017-2022) & (USD/Unit)
Table 59. Global Corticosteroid Injections for Joint Pain Price by Type (2023-2028) & (USD/Unit)
Table 60. Global Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
Table 61. Global Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
Table 62. Global Corticosteroid Injections for Joint Pain Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Corticosteroid Injections for Joint Pain Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Corticosteroid Injections for Joint Pain Price by Application (2017-2022) & (USD/Unit)
Table 65. Global Corticosteroid Injections for Joint Pain Price by Application (2023-2028) & (USD/Unit)
Table 66. North America Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
Table 67. North America Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
Table 68. North America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
Table 71. North America Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
Table 72. North America Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
Table 73. North America Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
Table 74. Europe Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
Table 75. Europe Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
Table 76. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
Table 79. Europe Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
Table 80. Europe Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
Table 81. Europe Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
Table 90. South America Corticosteroid Injections for Joint Pain Sales by Country (2017-2022) & (K Units)
Table 91. South America Corticosteroid Injections for Joint Pain Sales by Country (2023-2028) & (K Units)
Table 92. South America Corticosteroid Injections for Joint Pain Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Corticosteroid Injections for Joint Pain Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
Table 95. South America Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
Table 96. South America Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
Table 97. South America Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Corticosteroid Injections for Joint Pain Sales by Application (2023-2028) & (K Units)
Table 106. Corticosteroid Injections for Joint Pain Raw Material
Table 107. Key Manufacturers of Corticosteroid Injections for Joint Pain Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Corticosteroid Injections for Joint Pain Typical Distributors
Table 111. Corticosteroid Injections for Joint Pain Typical Customers

LIST OF FIGURES

Figure 1. Corticosteroid Injections for Joint Pain Picture
Figure 2. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type in 2021
Figure 3. Knee & Ankle
Figure 4. Hip Joint
Figure 5. Shoulder & Elbow
Figure 6. Facet Joints of the Spine
Figure 7. Others
Figure 8. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application in 2021
Figure 9. Hospital Pharmacies
Figure 10. Retail Pharmacies
Figure 11. Online Pharmacies
Figure 12. Global Corticosteroid Injections for Joint Pain Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 13. Global Corticosteroid Injections for Joint Pain Revenue and Forecast (2017-2028) & (USD Million)
Figure 14. Global Corticosteroid Injections for Joint Pain Sales (2017-2028) & (K Units)
Figure 15. Global Corticosteroid Injections for Joint Pain Price (2017-2028) & (USD/Unit)
Figure 16. Global Corticosteroid Injections for Joint Pain Production Capacity (2017-2028) & (K Units)
Figure 17. Global Corticosteroid Injections for Joint Pain Production Capacity by Geographic Region: 2022 VS 2028
Figure 18. Corticosteroid Injections for Joint Pain Market Drivers
Figure 19. Corticosteroid Injections for Joint Pain Market Restraints
Figure 20. Corticosteroid Injections for Joint Pain Market Trends
Figure 21. Global Corticosteroid Injections for Joint Pain Sales Market Share by Manufacturer in 2021
Figure 22. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Manufacturer in 2021
Figure 23. Corticosteroid Injections for Joint Pain Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 24. Top 3 Corticosteroid Injections for Joint Pain Manufacturer (Revenue) Market Share in 2021
Figure 25. Top 6 Corticosteroid Injections for Joint Pain Manufacturer (Revenue) Market Share in 2021
Figure 26. Global Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2028)
Figure 27. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2028)
Figure 28. North America Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (USD Million)
Figure 29. Europe Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (USD Million)
Figure 30. Asia-Pacific Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (USD Million)
Figure 31. South America Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (USD Million)
Figure 32. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue (2017-2028) & (USD Million)
Figure 33. Global Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
Figure 34. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Type (2017-2028)
Figure 35. Global Corticosteroid Injections for Joint Pain Price by Type (2017-2028) & (USD/Unit)
Figure 36. Global Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
Figure 37. Global Corticosteroid Injections for Joint Pain Revenue Market Share by Application (2017-2028)
Figure 38. Global Corticosteroid Injections for Joint Pain Price by Application (2017-2028) & (USD/Unit)
Figure 39. North America Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
Figure 40. North America Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
Figure 41. North America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2028)
Figure 42. North America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2028)
Figure 43. United States Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 44. Canada Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 45. Mexico Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 46. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
Figure 47. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
Figure 48. Europe Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2028)
Figure 49. Europe Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2028)
Figure 50. Germany Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. France Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. United Kingdom Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Russia Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 54. Italy Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 55. Asia-Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2028)
Figure 56. Asia-Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
Figure 57. Asia-Pacific Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2028)
Figure 58. Asia-Pacific Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2028)
Figure 59. China Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Japan Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Korea Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. India Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Southeast Asia Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Australia Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. South America Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
Figure 66. South America Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
Figure 67. South America Corticosteroid Injections for Joint Pain Sales Market Share by Country (2017-2028)
Figure 68. South America Corticosteroid Injections for Joint Pain Revenue Market Share by Country (2017-2028)
Figure 69. Brazil Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Argentina Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Type (2017-2028)
Figure 72. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Application (2017-2028)
Figure 73. Middle East & Africa Corticosteroid Injections for Joint Pain Sales Market Share by Region (2017-2028)
Figure 74. Middle East & Africa Corticosteroid Injections for Joint Pain Revenue Market Share by Region (2017-2028)
Figure 75. Turkey Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Egypt Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. Saudi Arabia Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. South Africa Corticosteroid Injections for Joint Pain Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Manufacturing Cost Structure Analysis of Corticosteroid Injections for Joint Pain in 2021
Figure 80. Manufacturing Process Analysis of Corticosteroid Injections for Joint Pain
Figure 81. Corticosteroid Injections for Joint Pain Industrial Chain
Figure 82. Sales Channel: Direct Channel vs Indirect Channel
Figure 83. Methodology
Figure 84. Research Process and Data Source


More Publications